Literature DB >> 2200316

Serodiagnosis of tuberculosis using an ELISA with antigen 5 and a hemagglutination assay with glycolipid antigens. Results in patients with newly diagnosed pulmonary tuberculosis ranging in extent of disease from minimal to extensive.

S L Chan1, Z Reggiardo, T M Daniel, D J Girling, D A Mitchison.   

Abstract

Hemagglutination tests with three glycolipid antigens, A1, B1, and C, and ELISA with antigen 5 were done on serum from Chinese patients with pulmonary tuberculosis and from normal subjects in Hong Kong. Tests with all four antigens were of similar efficiency, giving positive results in 30 to 52% of 88 smear-positive patients, in 16 to 22% of 37 smear-negative, culture-positive patients, in 5 to 13% of 76 culture-negative patients with radiologically active disease, in 5 to 11% of 217 culture-negative patients with inactive disease, and in 1 to 4% of 140 normal subjects. If tests were combined so that an overall positive was scored when all tests were positive, there was worse discrimination between patients and normal subjects; however, as suggested by the poor correlation between the results with pairs of the tests, better discrimination was obtained if an overall positive was scored when any of the tests was positive. A positive result in any of the four tests was found in 22% of all cases, including 58% of smear-positive patients, 32% of smear-negative, culture-positive patients, and 0.7% of normal subjects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200316     DOI: 10.1164/ajrccm/142.2.385

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  12 in total

Review 1.  Clinical utility of serodiagnosis of tuberculosis.

Authors:  S Mahadevan
Journal:  Indian J Pediatr       Date:  1997 Jan-Feb       Impact factor: 1.967

2.  Effect of growth state on transcription levels of genes encoding major secreted antigens of Mycobacterium tuberculosis in the mouse lung.

Authors:  Lanbo Shi; Robert North; Maria Laura Gennaro
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

Review 3.  Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis.

Authors:  Karen R Steingart; Nandini Dendukuri; Megan Henry; Ian Schiller; Payam Nahid; Philip C Hopewell; Andrew Ramsay; Madhukar Pai; Suman Laal
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

4.  Serological comparison of purified antigens 60 and 85A (P32) of Mycobacterium bovis BCG, and purified protein derivative, in active pulmonary tuberculosis.

Authors:  M Turneer; E Van Nerom
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

5.  Murine and human B cell epitope mapping of the Mycobacterium tuberculosis 10-kD heat shock protein using overlapping peptides.

Authors:  A Verbon; R A Hartskeerl; A H Kolk
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

6.  Serodiagnosis of childhood tuberculosis by ELISA.

Authors:  A S Bhatia; Sonika Gupta; Neeraj Shende; Satish Kumar; B C Harinath
Journal:  Indian J Pediatr       Date:  2005-05       Impact factor: 1.967

7.  Glycolipids of Mycobacterium tuberculosis strain H37Rv are potential serological markers for diagnosis of active tuberculosis.

Authors:  R P Tiwari; Dileep Tiwari; Sanjay K Garg; Ramesh Chandra; Prakash S Bisen
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

8.  Humoral immune responses against the Mycobacterium tuberculosis 38-kilodalton, MTB48, and CFP-10/ESAT-6 antigens in tuberculosis.

Authors:  Xueqiong Wu; Yourong Yang; Junxian Zhang; Bangying Li; Yan Liang; Chuiying Zhang; Mei Dong; Hongbing Cheng; Jufang He
Journal:  Clin Vaccine Immunol       Date:  2010-01-06

9.  Detection of lipoarabinomannan as a diagnostic test for tuberculosis.

Authors:  E Sada; D Aguilar; M Torres; T Herrera
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

10.  Immunoglobulin M antibody responses to Mycobacterium ulcerans allow discrimination between cases of active Buruli ulcer disease and matched family controls in areas where the disease is endemic.

Authors:  Daniel M N Okenu; Lazarus O Ofielu; Kirk A Easley; Jeannette Guarner; Ellen A Spotts Whitney; Pratima L Raghunathan; Ymkje Stienstra; Kwame Asamoa; Tjip S van der Werf; Winette T A van der Graaf; Jordan W Tappero; David A Ashford; C Harold King
Journal:  Clin Diagn Lab Immunol       Date:  2004-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.